Npsp

[al7bebe]

سهم طبي
After Hours Trade Reporting
After Hours
Last: $ 4.86 After Hours
High: $ 4.86
After Hours
Volume: 10,474 After Hours
Low: $ 4.3716
Last Trade: 4.44
Trade Time: 4:00pm ET
Change: 0.73 (19.68%)
Prev Close: 3.71
Open: 4.28
Bid: 4.56 x 100
Ask: 4.80 x 6500
1y Target Est: 7.92
Day's Range: 4.01 - 4.60
52wk Range: 2.74 - 8.96
Volume: 995,403
Avg Vol (3m): 357,668
Market Cap: 210.91M
P/E (ttm): N/A
EPS (ttm): -0.61
Div & Yield: N/A (N/A
--------------
السهم راح يحلق فوق باكر في الصباح
متابعه بريماركت باكر

 

[al7bebe]

علشان اكون واضح معاكم

Brean Murray Initiates Coverage on NPS Pharmaceuticals (NPSP) with a Buy

More News related to NPSP
NPS Pharmaceuticals to Present at Jefferies Healthcare Conference
Notable Analyst Rating Changes 6/11: RF, FITB, BBT, HBAN, STI, BAC, GSK Upgraded; UNH, TIN, ALV, VPRT Downgraded
Morning Movers 6/11: STAA, CPST, HGSI, CHDX, MBRX, OBCI Higher; LULU, UNH, LUB, LTON, PNFP Lower
STAA, MBRX, NPSP, HGSI, CPST, JAZZ, ESLR See Volume and Upside Price Action
Brean Murray Initiates Coverage on NPS Pharmaceuticals (NPSP) with a Buy
More News related to NPSP
More News related to New Coverage
Oscar Gruss Initiates Coverage on Quest Software (QSFT) with a Buy
Piper Jaffray Resumes Coverage on Alexion (ALXN) with a Buy; Warrants Premium to Peer Group
Wedbush Morgan Initiates Coverage on Celera (CRA) with a Hold
Dahlman Rose Initiates Coverage on James River Coal (JRCC)
Sterne Agee Starts DuPont (DD) at Neutral
More News related to New Coverage
June 11, 2009 8:44 AM EDT

Brean Murray initiates coverage on NPS Pharmaceuticals (Nasdaq: NPSP) with a Buy. Price target $11.

Brean analyst says, "With the current market value of the company below the value of the royalties from Sensipar and Regpara, we believe that NPSP's stock is significantly undervalued and is well poised to generate significant upside, driven by potential positive data for two pivotal Phase III trials, Gattex in short bowel syndrome and NPSP558 in hypoparathyroidism in 2H10."

http://www.streetinsider.com/New+Co...harmaceuticals+(NPSP)+with+a+Buy/4724063.html

-------------Brean Murray initiates coverage on NPS Pharmaceuticals (Nasdaq: NPSP) with a Buy. Price target $11.
َبْدأُ Brean موراي تغطيةً على مواد إن بي إس الصيدلانيةِ (ناسداك: إن بي إس بي) مَع a صفقة. سعر مطلوب 11$.



-----------------------------

 

[nouf]

طيب الهدف المتوقع كم ؟؟؟

 

[al7bebe]

طيب الهدف المتوقع كم ؟؟؟

اول هدف 5$ وزيادة

 

[البولندي]

حبيب وسهمك حبيب للمتابعه الجاده